AXL-IN-13 is a potent and orally active AXL inhibitor (IC50: 1.6 nM, Kd: 0.26 nM). AXL-IN-13 reverses TGF-beta1-induced epithelial-mesenchymal transition (EMT), and inhibits cancer cell migration and invasion[1].
Molecular Weight:
632.72
Purity:
98.03
CAS Number:
[2376928-82-2]
Formula:
C34H41FN6O5
Target:
FLT3,PDGFR,TAM Receptor
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted